For more than a year, the biopharma industry has had to swiftly react to various tariff threats from the Trump administration. Now, a Thursday announcement from the White House puts the U.S. tariff ...

We have watched in recent years a push by public officials to use overly broad language to expand restrictions on the public’s ability to monitor what they are doing. In the 2024 legislative session, ...